Co-Authors
This is a "connection" page, showing publications co-authored by ELSA ARRIBAS and LUMARIE SANTIAGO.
Connection Strength
2.585
-
Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study. J Surg Oncol. 2021 Apr; 123(5):1206-1214.
Score: 0.803
-
The role of three-dimensional printing in the surgical management of breast cancer. J Surg Oncol. 2019 Nov; 120(6):897-902.
Score: 0.725
-
Multimodality Imaging for 3D Printing and Surgical Rehearsal in Complex Spine Surgery. Radiographics. 2024 Mar; 44(3):e230116.
Score: 0.248
-
Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: breast conditions. 3D Print Med. 2023 Mar 23; 9(1):8.
Score: 0.232
-
Mimickers of breast malignancy: imaging findings, pathologic concordance and clinical management. Insights Imaging. 2021 Apr 20; 12(1):53.
Score: 0.203
-
Prospective Comparison of Synthesized Mammography with DBT and Full-Field Digital Mammography with DBT Uncovers Recall Disagreements That may Impact Cancer Detection. Acad Radiol. 2022 07; 29(7):1039-1045.
Score: 0.052
-
Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat. 2021 Jan; 185(1):1-12.
Score: 0.049
-
Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. Eur J Radiol. 2020 Sep; 130:109170.
Score: 0.048
-
Application of Three-Dimensional Printed Vascular Modeling as a Perioperative Guide to Perforator Mapping and Pedicle Dissection during Abdominal Flap Harvest for Breast Reconstruction. J Reconstr Microsurg. 2020 Jun; 36(5):325-338.
Score: 0.047
-
Imaging features of triple-negative breast cancers according to androgen receptor status. Eur J Radiol. 2019 May; 114:167-174.
Score: 0.044
-
A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951.
Score: 0.041
-
Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints. Ann Surg Oncol. 2018 Jul; 25(7):1953-1960.
Score: 0.041
-
Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. AJR Am J Roentgenol. 2011 Oct; 197(4):W761-8.
Score: 0.026
-
Investigating the limit of detectability of a positron emission mammography device: a phantom study. Med Phys. 2011 Sep; 38(9):5176-85.
Score: 0.026